Board of Directors

Danish Diabetes and Endocrine Academy (DDEA) is headed by a Board of Directors (BoD) of seven members with a well-balanced and broad representation of stakeholders, with regard to gender, age, national geography, and sector. 

Members' Profile and Competences

The BoD includes representation from early-career researchers, senior researchers, and clinicians, as well as universities, hospitals, and the life science industry, across diabetes and classical endocrinology fields.

The members have competence and experience as board members/chairpersons, researchers, or clinicians in diabetes and classical endocrinology fields, education and talent development, innovation and entrepreneurship, fundraising, public-private partnerships, impact assessment, and Novo Nordisk Foundation-funded initiatives and strategies.

Task and Responsibilities:

The principal tasks of the BoD are to:

  • define and decide the overall strategy and the strategy for DDEA’s four key activity areas and oversee its implementation

  • approve the annual accounts and budget, the annual programme for DDEA activities, and make the final decision on grant allocations

  • perform an annual evaluation of DDEA and its organisation, including impact assessment of the success criteria, key performance indicators, and other evaluation factors to decide whether the strategy for future activities needs adjusting.

Further information can be found in the Terms of References of the DDEA Board of Directors.

Board Members

Allan Flyvbjerg
Allan Flyvbjerg
MD, DMSc
Chairman of the Board of Directors (BoD) of DDEA and BoD Member of the European Association for the Study of Diabetes (EASD) and the Bagger-Sørensen Foundation
Anders Hoff
Anders Hoff
MA
Political Chief Research and Innovation, the Danish Association of the Pharmaceutical Industry
Jakob Dal
Jakob Dal
MD, PhD
Associate Professor, Aalborg University, and Senior Registrar, Aalborg University Hospital
Julie Abildgaard
Julie Abildgaard
MD, PhD
Resident, Capitol Region of Denmark, and Postdoc, Rigshospitalet
Kurt Højlund
Kurt Højlund
MD, PhD, DMSc
Chief Physician and Head of Research, Steno Diabetes Center Odense, Odense University Hospital, and Clinical Professor in Endocrinology, University of Southern Denmark
Lise Wogensen Bach
Lise Wogensen Bach
MD, DMSc
Vice-Dean of Education, Faculty of Health, Aarhus University
Marie-Louise Hartoft-Nielsen
Marie-Louise Hartoft-Nielsen
MD
Clinical Director, the Novo Nordisk Foundation

Read more about our other bodies

Copyright © 2023 Danish Diabetes and Endocrine Academy. All Rights Reserved • Privacy Policy